All content for On AIRR - Immune receptors in the clinic is the property of AIRR-Community and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On AIRR 4: Understanding and engineering immune repertoires with Dr. Jacob Glanville
On AIRR - Immune receptors in the clinic
50 minutes 35 seconds
3 years ago
On AIRR 4: Understanding and engineering immune repertoires with Dr. Jacob Glanville
Dr. Jacob Glanville is founder and CEO of Centivax and founder of Distributed Bio, acquired by Charles River in 2021. His work focuses on understanding and engineering the repertoires of T and B cells to improve the response to pathogens. In this episode we discuss how to analyze receptor specificity and use this to create therapeutic antibodies and optimize vaccine response.
AIRR Community Meeting VI: “Exploring New Frontiers”: https://www.antibodysociety.org/the-airr-community/meetings/airr-community-meeting-vi-exploring-new-frontiers
iReceptor+ Seminar Series: http://www.ireceptor-plus.com/news-and-events/seminars
Comments are welcome to the inbox of onairr@airr-community.org or on social media under the hashtag #onAIRR. Further information can be found here: https://www.antibodysociety.org/the-airr-community/airr-c-podcast
